Dermatology NewsAbrocitinib efficacy dose-dependent, similar across AD age groupsDecember 15, 2021Atopic DermatitisPediatrics
Dermatology NewsCRP elevated in adults with AD and sleep disturbanceDecember 15, 2021Atopic Dermatitis
Dermatology NewsUpadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indicationDecember 15, 2021Psoriatic Arthritis
Dermatology NewsCOVID-19 asymptomatic infection rate remains highDecember 15, 2021COVID-19 UpdatesInfectious Diseases
Dermatology NewsPhysician gender pay gap isn’t news; health inequity is rampantDecember 14, 2021Business of MedicinePractice ManagementHealth Policy
Widespread Necrotizing Purpura and Lucio Phenomenon as the First Diagnostic Presentation of Diffuse Nonnodular Lepromatous LeprosyDecember 14, 2021Infectious Diseases
A Fatal Case of Hemophagocytic Lymphohistiocytosis Secondary to Anti-MDA5–Positive DermatomyositisDecember 13, 2021Rare Diseases
Dermatology NewsA 22-year-old presented with erythematous papules on her fingers and toesDecember 13, 2021Autoimmune DiseasesMedical Dermatology
Dermatology News12 state boards have disciplined docs for COVID misinformationDecember 13, 2021Business of MedicineCOVID-19 Updates
Dermatology NewsAbrocitinib approved for atopic dermatitis in EuropeDecember 13, 2021Atopic Dermatitis
